Macrocyclic beta-secretase inhibitors for treatment of Alzheimer's disease

Details for Australian Patent Application No. 2004204692 (hide)

Owner Merck & Co., Inc.

Inventors Stachel, Shawn J.; Vacca, Joseph P.; Coburn, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-B-2004204692

PCT Pub. Number WO2004/062625

Priority 60/438,630 07.01.03 US

Filing date 2 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 9 July 2009

International Classifications

C07D 273/02 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 July 2005 PCT application entered the National Phase

  PCT publication WO2004/062625 Priority application(s): WO2004/062625

9 July 2009 Application Accepted

  Published as AU-B-2004204692

5 November 2009 Standard Patent Sealed

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204702-Alignment of enhancers in cosmetic compositions

2004204683-Food and feed compositions including resistant starch